Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Astrazeneca Plc (AZN.LN)

Astrazeneca Plc (AZN.LN)
10,756.000 +137.999 (+1.30%) 09:20 ET [LSE]
10,752.000 x 78 10,753.999 x 137
Realtime by (Cboe BZX)
10,752.000 x 78 10,753.999 x 137
Realtime - - (-) -
Quote Overview for Wed, Apr 30th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
10,671.999
Day High
10,820.000
Open 10,820.000
Previous Close 10,618.001 10,618.001
Volume 93,862,993 93,862,993
Avg Vol 7,589,497 7,589,497
Stochastic %K 96.77% 96.77%
Weighted Alpha -11.58 -11.58
5-Day Change +409.999 (+3.96%) +409.999 (+3.96%)
52-Week Range 9,573.505 - 13,388.000 9,573.505 - 13,388.000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 161,218,839
  • Shares Outstanding, K 1,550,181
  • Annual Sales, $ 54,073 M
  • Annual Income, $ 7,035 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 4.04
  • Price/Cash Flow 18.18
  • Price/Book N/A
  • Price/Earnings ttm 30.65
  • Earnings Per Share ttm 4.50
  • Most Recent Earnings $0.96 on 02/06/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 2.99 (2.36%)
  • Most Recent Dividend 1.680 on 02/20/25
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
9,573.505 +12.52%
on 04/09/25
Period Open: 11,416.000
11,552.000 -6.75%
on 04/03/25
-644.001 (-5.64%)
since 03/28/25
3-Month
9,573.505 +12.52%
on 04/09/25
Period Open: 11,313.999
12,208.000 -11.76%
on 02/26/25
-542.000 (-4.79%)
since 01/30/25
52-Week
9,573.505 +12.52%
on 04/09/25
Period Open: 12,062.001
13,388.000 -19.54%
on 09/03/24
-1,290.002 (-10.69%)
since 04/30/24

Most Recent Stories

More News
Stocks Muted Before the Open With Focus on U.S. Economic Data and Amazon Earnings

March S&P 500 E-Mini futures (ESH25) are up +0.05%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.08% this morning as investors awaited a new round of U.S. economic data, remarks from Federal...

NVDA : 109.02 (+0.27%)
GOOGL : 160.16 (-0.28%)
MAERB.C.DX : 11,335.000 (+1.93%)
HON : 211.49 (+5.40%)
F : 10.15 (+1.30%)
SWKS : 61.60 (-0.82%)
AMGN : 288.56 (+1.93%)
ESH25 : 5,617.80s (-0.79%)
BMY : 49.22 (+1.57%)
JCI : 82.33 (+1.52%)
FTNT : 104.21 (+1.53%)
QCOM : 146.88 (-0.50%)
AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England

AZN.LN : 10,756.000 (+1.30%)
Stock Index Futures Gain as Bond Yields Fall, U.S. Economic Data in Focus

March S&P 500 E-Mini futures (ESH25) are up +0.35%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.48% this morning, pointing to a positive opening on Wall Street as Treasury yields edged lower,...

KLAC : 687.95 (-0.83%)
AMAT : 149.55 (-0.82%)
USB : 40.50 (+0.80%)
SNOW : 160.35 (+0.87%)
JBHT : 130.40 (-0.42%)
SLB : 34.11 (+0.03%)
TXN : 160.77 (-1.03%)
ESH25 : 5,617.80s (-0.79%)
UNH : 409.23 (-2.56%)
TFC : 38.76 (+1.10%)
STT : 88.53 (+1.10%)
RF : 20.52 (+0.29%)
Stock Index Futures Inch Higher as Investors Mull Size of Fed Rate Cut, U.S. Economic Data on Tap

September S&P 500 E-Mini futures (ESU24) are up +0.23%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.08% this morning, while Treasury yields slumped after fresh U.S. economic data left investors...

ROKU : 69.28 (+1.67%)
NQU24 : 19,808.01s (-0.21%)
KR : 71.38 (+1.44%)
MU : 76.88 (-2.14%)
ORCL : 140.79 (+0.46%)
RH : 184.60 (+0.58%)
WBD : 8.77 (+0.80%)
AZN.LN : 10,756.000 (+1.30%)
ADBE : 370.98 (+0.64%)
ESU24 : 5,699.99s (-0.31%)
MRNA : 27.82 (+1.31%)
ARM : 111.65 (-0.38%)
Drugs to treat diabetes, heart disease and blood cancers among those affected by price negotiations

The Biden administration says Medicare recipients will save about $1.5 billion dollars on medications to for diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with...

RILY : 2.90 (-3.01%)
RSG : 247.70 (+0.65%)
AZN.LN : 10,756.000 (+1.30%)
BMY : 49.22 (+1.57%)
Astrazeneca: Q2 Earnings Snapshot

Astrazeneca: Q2 Earnings Snapshot

AZN.LN : 10,756.000 (+1.30%)
Stock Index Futures Mixed Ahead of More Fed Speak, Nvidia Earnings Awaited

June S&P 500 E-Mini futures (ESM24) are up +0.03%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.08% this morning as investors awaited further comments from Federal Reserve officials while also...

NVDA : 109.02 (+0.27%)
SFSN.Z.EB : 110.600 (-0.09%)
JPM : 244.62 (+0.58%)
MU : 76.88 (-2.14%)
NOVA : 0.2255 (-1.14%)
LRMR : 2.39 (+1.70%)
HPQ : 25.52 (+0.51%)
M : 11.43 (-1.38%)
URBN : 53.26 (+1.12%)
TOL : 100.50 (-0.61%)
ESM24 : 5,471.89s (-0.09%)
ZM : 77.55 (+1.83%)
AstraZeneca pulls its COVID-19 vaccine from the European market

The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled

AZN : 71.71 (+2.55%)
$SPX : 5,560.83 (+0.58%)
AZN.LN : 10,756.000 (+1.30%)
$DOWI : 40,527.62 (+0.75%)
$IUXX : 19,544.95 (+0.61%)
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic

AZN : 71.71 (+2.55%)
AZN.LN : 10,756.000 (+1.30%)
GSK.LN : 1,477.500 (+3.18%)
GSK : 38.97 (+2.39%)
International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall, Tuesday, 3/19/2024

Stocks that traded heavily or had substantial price changes on Tuesday: International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall

AZN : 71.71 (+2.55%)
SMCI : 36.00 (-3.41%)
CRNX : 33.31 (+0.60%)
IP : 47.63 (+0.32%)
UL : 63.14 (-0.06%)
AZN.LN : 10,756.000 (+1.30%)
FCX : 37.17 (-0.19%)
FUSN : 21.55 (+0.14%)
ULVR.LN : 4,734.000 (+1.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 11,480.000
2nd Resistance Point 11,050.000
1st Resistance Point 10,834.000
Last Price 10,756.000
1st Support Level 10,188.000
2nd Support Level 9,758.000
3rd Support Level 9,542.000

See More

52-Week High 13,388.000
Fibonacci 61.8% 11,930.862
Fibonacci 50% 11,480.752
Fibonacci 38.2% 11,030.642
Last Price 10,756.000
52-Week Low 9,573.505

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective